Rangan (Ronnie) Maitra

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter by Year

Filter by Publication Type

Search Results

Design, synthesis, and pharmacological evaluation of JDTic analogs to examine the significance of the 3-and 4-methyl substituents

Pyrazole Derivatives as Cannabinoid Receptor 1 Antagonists

Inhibition of alcoholic steatosis by a type 1 cannabinoid receptor antagonist: ESBRA 2015 Meeting Abstract P-16

Modulation of pain in pediatric sickle cell disease: Understanding the balance between endothelin mediated vasoconstriction and apelin mediated vasodilation

Design, Synthesis, and Biological Evaluation of (3R)-1,2,3,4-Tetrahydro-7-hydroxy-N-[(1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dim ethyl-1-piperidinyl]methyl]-2-methylpropyl]-3-isoquinolinecarboxamide (JDTic) Analogues: In Vitro Pharmacology and ADME Profi

In vivo evaluation of the peripherally selective CB1 receptor antagonist RTI-13329-2 in a mouse model of diet-induced weight gain

Identifying structural determinants of potency for analogs of apelin-13: Integration of C-terminal truncation with structure-activity

A Rapid Membrane Potential Assay to Monitor CFTR Function and Inhibition

Peripherally Selective Diphenyl Purine Antagonist of the CB1 Receptor

Diphenyl purine derivatives as peripherally selective cannabinoid receptor 1 antagonists

Structural analogs of pyrazole and sulfonamide cannabinoids: Effects on acute food intake in mice

Decreased Maternal Plasma Apelin Concentrations in Preeclampsia

Design and synthesis of cannabinoid receptor 1 antagonists for peripheral selectivity

Towards rational design of cannabinoid receptor 1 (CB1) antagonists for peripheral selectivity

A disease-relevant high-content screening assay to identify anti-inflammatory compounds for use in cystic fibrosis

Synthesis and Biological Evaluation of Bivalent Ligands for the Cannabinoid 1 Receptor

A Disease-Related High Content Screening Assay to Identify Anti-Inflammatory Compounds for Use in Cystic Fibrosis

Development of a functional HTS assay for the APJ receptor

Inhibition of NFkappaB by the natural product Withaferin A in cellular models of Cystic Fibrosis inflammation

Altered Biogenesis of DeltaF508-CFTR Following Treatment with Doxorubicin